"Located off Genesee Avenue, just east of I-5 in the UTC area of La Jolla, Scripps Whitter Diabetes Institute provides screenings, education and support services to people with prediabetes, gestational diabetes, and type 1 and type 2 diabetes. Our diabetes services include: - One-on-one training on continuous glucose monitoring and insulin pumps - Customized health planning, including medical nutrition therapy and exercise strategies - Community programs, including peer support groups - Access to clinical trials - Multilingual educational handouts"

During the past decade, Scripps Whittier Diabetes Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scripps Whittier Diabetes Institute" #1 sponsor was "Scripps Whittier Diabetes Institute" with 11 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored, "DexCom, Inc." with 2 trials sponsored and "Glooko" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scripps Whittier Diabetes Institute" #1 collaborator was "San Diego State University" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "Blue Shield Foundation" with 1 trials as a collaborator and "DexCom, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Scripps Whittier Diabetes Institute" are "Diabetes Mellitus, Type 2" (6 trials), "Type 2 Diabetes Mellitus" (6 trials), "Type 1 Diabetes Mellitus" (4 trials), "Diabetes" (2 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials). Many other conditions were trialed in "Scripps Whittier Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Scripps Whittier Diabetes Institute" are "Drug" (14 trials), "Behavioral" (8 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AC2993" (2 trials), "Project Dulce + Dulce Digital" (2 trials), "Tirzepatide" (2 trials) and "AC2993 10.0 mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scripps Whittier Diabetes Institute" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Scripps Whittier Diabetes Institute". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Scripps Whittier Diabetes Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scripps Whittier Diabetes Institute, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".